(More on Colombia here: /colombia)
On May 16, 2016, 122 health, trade, and intellectual property experts defended the Colombian government’s right to issue a compulsory license on imatinib, an expensive leukemia drug that is being sold at a high price by the Swiss drug company Novartis, in a letter to Colombian President Juan Manuel Santos.
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) May 16th, 2016 Sally Hu, Ph.D., M.B.A., Senior Licensing and Patenting Manager, Office of Technology Transfer and Innovation Access, National Institute of Dental and Craniofacial… Continue Reading
SCCR 32 Conclusions proposed by the chair. Late Friday May 13, 2016. Nigeria, Bahamas, Brazil, South Africa and Egypt were exceptionnaly interesting. Here is most of what was said including the reading of the proposed conclusions and the comments from… Continue Reading
KEI: I wanted to just address some of the issues on the cross-border relationship with the exceptions. I know the publisher mentioned mention to three step test. There are three important exceptions that are not related to the three step… Continue Reading
> SOUTH AFRICA: Thank you, Mr. Chairman. At the outset, South Africa supports the statement made by Nigeria on behalf of the Africa Group. 2015 was a milestone in the global calendar. We adopted agenda 2030, which outlined 17 goals… Continue Reading
Day 4. May 12, 2016 After the Chair Summary of the previous discussions on libraries and archives limitations and exceptions we heard the goup statements. In brief, Group B (the rich countries) stated that the discussions should continue to get… Continue Reading
>> EIFL.NET: I will start with retracted and withdrawn works. So libraries and archives have a mandate to pre seven public record for the future. In the analog aenvironment exhaustion to the distribution right provides legal means to insure its… Continue Reading
>> SAA: Thank you, Mr. Chair. Orphan works, what an appropriate name for the stuff of everyday life that we all create? Diaries, business memos and photographs that we never bother to mark with our own names. Most of it… Continue Reading
Speaking on behalf of the American University programme on information justice and Intellectual Property. And I speak as an educator myself and also on behalf of a larger network that I coordinate called the global expert network on user rights which is a network of educators.April 28, 2016 letter regarding US Senate Finance threats over compulsory license on Novartis cancer drug patents
Update: english translation of letter now available at end this blog.